| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.0073 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0094 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.0089 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |